Parasitic pericarditis

Article written and reviewed by Dr Luca Moretti

Parasitic pericarditis includes involvement of the pericardium caused by protozoa or helminths through direct invasion, extension from a nearby site, rupture of a cystic lesion, or the host inflammatory response. It does not identify a single disease with a uniform course and treatment. The common denominator is a causal relationship with a parasitic disease, which must be demonstrated or supported by a convincing combination of epidemiologic, microbiologic, and anatomic data.

The finding may consist of inflammation without a large effusion, an exudative collection, tamponade, or, more rarely, progression to constriction. In many infections, however, the predominant cardiac injury is myocardial: a small effusion during parasitic myocarditis is not equivalent to isolated pericarditis. This distinction is essential in Chagas disease, toxoplasmosis, and trichinellosis, in which arrhythmias and ventricular dysfunction may affect prognosis more than the pericardial component.

Documented forms are uncommon and often described in limited case series. Assessment should avoid both automatic exclusion in a non-endemic country and excessive attribution to a positive serologic test. Migration, travel, food exposures, and immunosuppression modify probability, but none of these elements replaces recognition of the mechanism responsible for cardiac injury.

Etiologies and epidemiologic settings

Cystic echinococcosis, caused by Echinococcus granulosus sensu lato, may localize to the heart and pericardium. Humans acquire the infection by accidentally ingesting eggs shed by canids, not simply by eating meat containing cysts. The larva may reach the circulation and develop a cystic lesion, more often in the liver or lung and only rarely in the heart. Contact with pastoral environments, origin from endemic areas, and previous localizations are clues, but exposure may have occurred many years earlier.

A cardiac cyst may remain silent for a long time, grow within the myocardium, or extend toward the pericardium. Pericardial involvement may be primary or secondary to rupture, extension, or dissemination from other sites. Risk does not depend only on size: location, relationships with chambers and coronary arteries, viability, and wall integrity determine the consequences. The natural history of hepatic cysts cannot automatically be transferred to the heart, where even an apparently inactive lesion may retain mechanical risk.

Invasive amebiasis caused by Entamoeba histolytica may be complicated by a liver abscess. A left-lobe lesion, because of its anatomic proximity to the diaphragm and pericardial sac, may spread or rupture into the pericardium, causing a rapidly severe presentation. Intestinal disease may be absent at the time of extraintestinal presentation. It is therefore incorrect to exclude amebiasis because concurrent diarrhea is absent or to interpret a negative stool examination as definitive exclusion of a liver abscess.

In Chagas disease, Trypanosoma cruzi causes mainly acute myocarditis and, in the chronic course, cardiomyopathy with electrical disturbances and ventricular dysfunction. An effusion may accompany the acute phase or reactivation, especially in immunocompromised patients. Vector exposure in endemic areas and congenital, oral, transfusion-related, or transplant transmission require different diagnostic contexts. Chronic seropositivity does not prove that new chest pain or a new effusion is due to reactivation: parasitic activity and alternative causes must be assessed.

Toxoplasmosis involving the heart is particularly relevant in patients with severe immunosuppression or after transplantation and may include myocarditis and pericardial involvement. Isolated IgG positivity generally indicates previous exposure and does not prove active localization. Trichinellosis, by contrast, is linked to ingestion of raw or undercooked meat containing larvae, including game. The systemic picture with fever, myalgia, periorbital edema, and eosinophilia may be accompanied by cardiac injury, often predominantly myocardial and immune-inflammatory.

Other rare parasitic diseases have been associated with effusion or cardiac inflammation, but the level of documentation varies. Not every pericardial abnormality during malaria, leishmaniasis, or other infections proves invasion of the sac: anemia, organ dysfunction, volume overload, and concomitant processes may contribute. An indiscriminate list of organisms does not replace plausibility assessment. Investigation should begin with the actual syndrome and exposures, maintaining the distinction among temporal association, systemic cardiac involvement, and proven pericardial localization.

Pathogenesis and pathophysiology of pericardial injury

Tissue localization may produce an inflammatory response that increases permeability and exudate formation. The intensity and composition of injury depend on the organism and immune status. Some protozoa primarily involve myocardial cells, with a secondary pericardial reaction; other scenarios involve entry into the sac of material from a nearby focus. The presence of fluid must therefore be interpreted in anatomic context rather than regarded as sufficient proof of parasite replication within the pericardium.

In echinococcosis, cyst growth may compress adjacent structures without clinically evident pericarditis. Rupture into the sac introduces antigenic material and, if viable, elements capable of secondary dissemination. Acute inflammation, effusion, and hypersensitivity reactions may result. Intracardiac rupture may instead cause systemic or pulmonary embolization depending on location. Distinguishing these events is important because sudden collapse may result from tamponade, anaphylaxis, embolism, or a combination of mechanisms.

In amebic extension, passage from a liver abscess to the pericardium creates an anatomic complication that systemic therapy alone may not control promptly. Necrotic and inflammatory material may accumulate rapidly, with cardiac compression and possible superinfection. The problem therefore requires simultaneous definition of the pericardial collection, hepatic cavity, and any communication. Evacuating the pericardium without addressing a still-communicating source may leave the patient exposed to renewed contamination.

The eosinophilic response may contribute to injury in some helminth infections but is neither universal nor specific. Activated eosinophils may contribute to tissue injury and cardiac inflammation; on the other hand, drugs, vasculitis, and hypereosinophilic syndromes cause similar presentations without parasites. Absence of eosinophilia does not exclude echinococcosis or protozoal disease and may be influenced by disease phase and treatment. Eosinophils in blood or fluid guide the pathway but do not identify the etiology by themselves.

Cardiac tamponade depends on increased pericardial pressure and reduced filling, not on an identical fluid volume in every patient. Cyst rupture or acute extension may be particularly dangerous because of the rapid accumulation. Adhesions and septa may cause regional compression and make echocardiographic signs atypical. Coexisting anaphylactic or infectious vasodilation further modifies the presentation: correction of one component does not guarantee resolution of the entire shock state.

Organization of the exudate may leave adhesions and fibrosis, with possible chronic limitation of filling. Constrictive physiology may coexist with effusion or become evident after drainage. In patients with associated myocardial injury, pericardial constraint must be distinguished from intrinsic ventricular dysfunction. Persistent exercise intolerance cannot automatically be explained as residual pericarditis: ventricular dysfunction, arrhythmias, anemia, and systemic disease may contribute even after the collection has resolved.

Clinical manifestations and recognition of suspicion

Pericardial symptoms include pleuritic or positional chest pain, dyspnea, and sometimes fever but may be absent in subacute or cystic forms. A friction rub supports inflammatory involvement when present but is not sensitive enough to exclude it when absent. Palpitations, syncope, and atypical pain require assessment of the myocardium, conduction system, and possible coronary compression. Clinical severity is not proportional to pain intensity: a patient with little pain may have a hemodynamically significant collection.

The geographic history should reconstruct place of birth and residence, prolonged stays, and travel without limiting the assessment to the preceding weeks. Exposure in an endemic region modifies probability but must be linked to actual routes of transmission. Dietary habits, consumption of game, potentially contaminated water and food, contact with livestock environments, and previous parasitic diseases point toward different investigations. Transfusions, transplants, and maternal history may also be relevant when considering Chagas disease.

In cardiac echinococcosis, a long asymptomatic phase may precede dyspnea, pain, arrhythmias, or sudden presentation. Urticaria, bronchospasm, and hypotension associated with a suspicious cystic lesion suggest rupture with an anaphylactic reaction. These findings require urgent management and should not be interpreted as a simple inflammatory flare. A known hepatic cyst increases the plausibility of cardiac localization, but its absence does not exclude it: the heart may be the first recognized site.

Amebic pericarditis should enter the differential diagnosis when fever, epigastric or hypochondrial pain, hepatic findings, and effusion coexist in a compatible setting. Referred shoulder pain, diaphragmatic irritation, and thoracic manifestations may predominate over intestinal symptoms. Progression may be rapid when communication with the sac develops. In this situation, investigation for a left-lobe abscess has immediate practical significance because it identifies a potentially treatable source in addition to the cardiac problem.

In trichinellosis, the sequence of food exposure, gastrointestinal symptoms, and a subsequent febrile myalgic syndrome is particularly useful. Periorbital edema, elevated muscle enzymes, and eosinophilia strengthen suspicion but are not all mandatory. In toxoplasmosis in immunocompromised patients, systemic or neurologic signs may predominate while cardiac injury remains initially subtle. Worsening after intensification of immunosuppression requires consideration of reactivation without confusing a marker of past exposure with confirmation of active disease.

The hemodynamic examination assesses blood pressure, heart rate, perfusion, jugular veins, and signs of congestion. Hypotension, oliguria, altered mental status, or rapidly worsening dyspnea require urgent echocardiography and stabilization. Persistent edema and ascites may indicate constrictive physiology or ventricular failure. The general examination should look for hepatomegaly, skin lesions, neurologic deficits, and muscle signs because the distribution of manifestations helps identify a systemic syndrome and select diagnostic samples with the highest expected yield.

Cardiologic, parasitologic, and differential diagnosis

Echocardiography defines effusion, signs of tamponade, ventricular function, and any masses. A cystic lesion requires attention to location, wall, contents, membranes, and possible daughter cysts, but no single feature should be interpreted out of context. CT and magnetic resonance further define relationships with the myocardium, coronary arteries, chambers, and mediastinum, as well as extracardiac sites. The goal is not merely to name the mass: anatomy determines the risk of diagnostic procedures and treatment options.

When a hydatid cyst is suspected, an unplanned diagnostic puncture may cause spillage of material, dissemination, and anaphylaxis. The mass should not be treated as an ordinary effusion to aspirate, nor should percutaneous techniques used for some hepatic cysts be automatically transferred to the heart. If tamponade coexists, decompression remains urgent but should be approached with imaging guidance and specialist expertise, distinguishing free fluid from the cyst and avoiding accidental traversal of the lesion.

Serology for echinococcus is supportive and may be negative even with cardiac localization; imaging and context remain central. For T. cruzi, strategy changes with phase: in chronic disease confirmation requires appropriate serologic tests, whereas in acute disease or reactivation demonstration of the parasite and molecular methods become important. Interpretation must account for laboratory performance and epidemiology, avoiding attribution of cardiac activity to a single uncontextualized positive result.

For Entamoeba histolytica, specific tests distinguish the pathogen from morphologically similar species. Serology may support extraintestinal diagnosis but may persist after previous infection; antigen or molecular testing on appropriate samples completes the pathway. Stool microscopy alone has limitations and may be negative with a liver abscess. Fluid obtained for a clinical indication should also be studied for bacteria and other causes: the color or consistency of material alone does not establish a parasitologic diagnosis.

Active toxoplasmosis requires correlation among immune status, clinical picture, serology, and, when indicated, PCR or histology. Isolated IgG does not document reactivation; molecular results must also be interpreted according to site and context. In trichinellosis, dietary history, eosinophilia, muscle enzymes, and serology contribute to diagnosis, recognizing that antibodies may not be detectable early. Muscle biopsy has selected indications, does not automatically replace less invasive tests, and should answer a specific clinical question.

The differential diagnosis includes tuberculous pericarditis, pyogenic or fungal infections, neoplasms, and immune-mediated diseases. In the presence of eosinophilia, drug reactions, vasculitis, and hypereosinophilic syndromes should also be considered; a cystic mass may be congenital or neoplastic. A pericardial cyst finding therefore requires characterization before being labeled parasitic. The final diagnosis should explicitly state which elements demonstrate the organism, which document cardiac injury, and which support the causal relationship between the two.

Further investigations and definition of disease

Once a probable cause has been identified, the organ distribution must be defined. In echinococcosis, liver and lung imaging looks for concomitant sites, while other districts are assessed according to symptoms and findings. In amebiasis, abdominal imaging should describe abscess size, location, and relationships, particularly proximity to the diaphragm and pericardium. The presence of a communication changes the strategy compared with a small reactive effusion because it indicates possible persistent contamination.

Distinguishing pericarditis from myocarditis requires ECG, troponin, echocardiography, and, in selected cases, magnetic resonance. Elevated troponin does not by itself define the mechanism, but together with dysfunction or arrhythmias it requires assessment of a myocardial component. In Chagas disease, rhythm and conduction monitoring may be a priority; a modest effusion should not distract from potentially dangerous blocks or arrhythmias. The duration of surveillance depends on the cardiac picture, not only on disappearance of fluid.

Immune assessment is essential in opportunistic protozoal infections. HIV, intensity of immunosuppression, and transplant history influence the probability of reactivation and the choice of tests. Neurologic findings and other signs of dissemination should be sought when relevant. Any modification of immunosuppressants requires coordination with the specialist managing the underlying disease: reducing infectious risk and preventing rejection or flare are simultaneous goals that cannot be solved through standardized withdrawal.

Cyst characterization must be precise enough to allow surgical planning. Relationships with the coronary arteries, septa, valve apparatus, and ventricular walls determine access and risk. An apparently extracardiac lesion may have important adhesions or continuity not clarified by the initial echocardiogram. Multidisciplinary assessment also includes rupture risk, potential embolization, and the need to treat other sites. Classification used for hepatic cysts provides morphologic information but does not by itself determine management in the heart.

Before therapy, baseline parameters useful for distinguishing toxicity from progression are recorded: complete blood count, liver and renal function, electrolytes, and any pre-existing neurologic abnormalities. Albendazole treatment may require hematologic and hepatic surveillance; benznidazole and nifurtimox have tolerability profiles that affect adherence and completion. Toxoplasmosis regimens require attention to bone marrow toxicity and interactions. Pregnancy, age, and comorbidities further modify the balance, making a single protocol inappropriate for all parasitic diseases.

Diagnostic certainty should be reassessed when data and course are discordant. A seropositive patient may simultaneously have tuberculosis or neoplasia; improvement after drainage documents hemodynamic benefit, not necessarily correctness of etiologic attribution. It is useful to separate evidence of systemic infection, evidence of cardiac disease, and evidence of current activity. This distinction avoids both prolonged antiparasitic therapy without a demonstrated target and failure to identify a still-present anatomic source.

Antiparasitic treatment and management of acute complications

Specific therapy depends on the organism and site: there is no universal antiparasitic drug for pericardial effusion. Hemodynamic stabilization proceeds in parallel with etiologic treatment. In tamponade, decompression should not be delayed while waiting for a drug to reduce inflammation. A possible hydatid cyst, however, changes the technique and requires expert planning. When anaphylaxis or sepsis coexist, these components must also be treated because fluid evacuation alone may not restore perfusion.

In cardiac echinococcosis, surgery is frequently necessary to remove the lesion and prevent rupture or compromise of adjacent structures. Albendazole may accompany the strategy, with timing and duration defined according to location, surgery, and dissemination risk. Perioperative choices require an experienced center and cannot be automatically inferred from hepatic protocols. Treatment should minimize spillage of cyst contents and take into account the potential toxicity of scolicidal substances to cardiac structures.

In amebic pericarditis caused by extension from an abscess, a drug active against tissue disease, such as metronidazole, is combined with control of collections and any communication. After tissue treatment, an appropriate luminal agent is required to eradicate residual intestinal colonization; regression of the abscess does not guarantee this eradication. Pericardial drainage and management of the hepatic focus depend on anatomy and severity. Conservative strategies for an uncomplicated abscess cannot be transferred without qualification to rupture toward the heart.

For Trypanosoma cruzi, benznidazole or nifurtimox are etiologic drugs. Acute and reactivated infections require treatment; in chronic disease the decision depends on age, stage, and individual characteristics. Parasite control does not replace treatment of arrhythmias or heart failure and does not imply reversibility of established cardiomyopathy. Acute pericarditis in a patient with chronic Chagas disease should therefore be assessed without assuming that every cardiac manifestation will respond to the same antiparasitic intervention.

In toxoplasmosis that is clinically significant, systemic regimens include combinations such as pyrimethamine, sulfadiazine, and folinic acid, or selected alternatives according to host, tolerability, and availability. Folinic acid limits pyrimethamine-related hematologic toxicity and is not an optional detail of the regimen. Trichinellosis is treated with albendazole or mebendazole; efficacy also depends on the phase of infection. Corticosteroids may be necessary in severe inflammatory forms, under antiparasitic coverage and specialist assessment, not as an automatic response to any eosinophilia.

Anti-inflammatory control with NSAIDs or colchicine may be considered in selected presentations, but evidence specific to the different parasitic diseases is limited and these drugs do not replace etiologic treatment. Before substantial immunosuppression, exposures compatible with other helminth infections, including strongyloidiasis, require attention because corticosteroids may promote severe infectious complications. If the course remains unfavorable, diagnosis, source, parasitic activity, and structural injury should be reassessed rather than empirically prolonging treatments unable to correct a mechanical lesion.

Prognosis, surveillance, and sequelae

Prognosis varies widely among a mild pericardial reaction, an unruptured cardiac cyst, and a complication with tamponade or dissemination. Aggregate statistics for cardiac parasitic diseases do not represent the risk of pericarditis alone. Surgical series also select particular patients and anatomies. Individual assessment should consider pathogen, site, structural integrity, ventricular function, and the possibility of eradication, as well as the conditions that favored disease or reactivation.

In the short term, effusion and perfusion are monitored with repeat echocardiography according to the course. Worsening after therapy may result from residual collection, bleeding, inflammation, progression of the source, or a procedural complication. Reduced pain does not exclude these problems, and normalization of eosinophils does not prove cure. If myocardial injury is present, monitoring should include ventricular function and rhythm because electrical complications may persist independently of the pericardial course.

After treatment of echinococcosis, surveillance should be prolonged. Local recurrences and secondary localizations may appear years later; the 2024 systematic review supports at least ten years of follow-up for cardiac disease. Imaging is central, while isolated serology does not reliably define viability or cure. The program should consider the original anatomy, any spillage of material, and other involved sites, without stopping follow-up simply because the first postoperative examination is favorable.

In complicated amebiasis, cure requires control of the hepatic focus, pericardial collection, and intestinal reservoir. Persistent fever or a new collection requires consideration of incomplete drainage, residual communication, and bacterial superinfection. A radiologic cavity may regress more slowly than symptoms, so persistence alone does not necessarily indicate failure. The decision to prolong or modify therapy should integrate clinical evolution and imaging features, avoiding both premature discontinuation and unnecessarily prolonged treatment.

Residual constriction presents with congestion and filling limitation and requires a dedicated hemodynamic pathway. It must be distinguished from cardiomyopathy, pulmonary hypertension, and volume overload related to other diseases. Any indication for pericardiectomy depends on persistence, severity, and reversibility of the constraint, not merely on a history of parasitic disease. In parallel, hepatic toxicity, cytopenias, and neurologic adverse effects of drugs should be recognized promptly because they may limit completion of necessary therapy.

Prevention of recurrence includes control of exposures and, in opportunistic infections, management of immunosuppression and preventive strategies appropriate to the specific disease. Food hygiene, adequate cooking of meat, and measures against exposure to echinococcus eggs address different routes of transmission and are not interchangeable. During cardiologic follow-up, symptom recovery, control of the organism, and absence of sequelae must be assessed separately: only their integration accurately describes the outcome of care.

References
1. Schulz-Menger J et al. 2025 ESC Guidelines for the management of myocarditis and pericarditis. European Heart Journal. 2025;46(40):3952-4041.
2. Klein AL et al. Pericardial Diseases: International Position Statement on New Concepts and Advances in Multimodality Cardiac Imaging. JACC: Cardiovascular Imaging. 2024;17(8):937-988.
3. Adler Y et al. 2015 ESC Guidelines for the diagnosis and management of pericardial diseases: The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC). Endorsed by: The European Association for Cardio-Thoracic Surgery (EACTS). European Heart Journal. 2015;36(42):2921-2964.
4. Hidron A et al. Cardiac Involvement with Parasitic Infections. Clinical Microbiology Reviews. 2010;23(2):324-349.
5. Bumann S et al. Cardiac cystic echinococcosis-A systematic review and analysis of the literature. PLOS Neglected Tropical Diseases. 2024;18(5):e0012183.
6. Centers for Disease Control and Prevention. Clinical Treatment of Echinococcosis. Centers for Disease Control and Prevention. n.d. Online institutional resource. Accessed September 26, 2026. https://www.cdc.gov/echinococcosis/hcp/clinical-care/index.html.
7. Centers for Disease Control and Prevention. Clinical Care of Chagas Disease. Centers for Disease Control and Prevention. n.d. Online institutional resource. Accessed September 26, 2026. https://www.cdc.gov/chagas/hcp/clinical-care/index.html.
8. Centers for Disease Control and Prevention. Clinical Care of Toxoplasmosis. Centers for Disease Control and Prevention. n.d. Online institutional resource. Accessed September 26, 2026. https://www.cdc.gov/toxoplasmosis/hcp/clinical-care/index.html.
9. Centers for Disease Control and Prevention. Clinical Care of Trichinellosis. Centers for Disease Control and Prevention. n.d. Online institutional resource. Accessed September 26, 2026. https://www.cdc.gov/trichinellosis/hcp/clinical-care/index.html.
10. Centers for Disease Control and Prevention. Post-Travel Diarrhea. CDC Yellow Book: Health Information for International Travel. 2026. Online institutional resource. Accessed September 26, 2026. https://www.cdc.gov/yellow-book/hcp/post-travel-evaluation/post-travel-diarrhea.html.
11. Centers for Disease Control and Prevention. Clinical Overview of Strongyloides. Centers for Disease Control and Prevention. n.d. Online institutional resource. Accessed September 26, 2026. https://www.cdc.gov/strongyloides/hcp/clinical-overview/index.html.
12. Roberts WC. Pericardial heart disease: its morphologic features and its causes. Proceedings (Baylor University Medical Center). 2005;18(1):38-55.
13. Spodick DH. Acute cardiac tamponade. New England Journal of Medicine. 2003;349(7):684-690.
14. Welch TD et al. Echocardiographic diagnosis of constrictive pericarditis: Mayo Clinic criteria. Circulation: Cardiovascular Imaging. 2014;7(3):526-534.
15. Sagristà-Sauleda J et al. Effusive-constrictive pericarditis. New England Journal of Medicine. 2004;350(5):469-475.